Canadian Medical Assocation

CMA activity and submissions

2018

October 2, 2018

CMA submission: Implementation of national pharmacare

In this submission to the Advisory Council on the Implementation of National Pharmacare, the CMA urges the federal government to explore universal coverage for 125 essential medicines.

June 1, 2018

CMA Member Voice e-Panel

A CMA e-Panel surveys physicians’ experiences prescribing medications and their thoughts on what a national pharmacare program should look like.

2017

June 28, 2017

CMA response: Patented Medicines Regulations Consultations

The CMA calls for revisions to Patented Medicines Prices Review Board regulations to ensure: a) transparency and clarity in setting patented medicine prices; b) the lowest possible costs; and c) continued access to a wide variety of pharmaceutical products

March 4, 2017

Position statement on prescription drug shortages in Canada

A new CMA policy on prescription drug shortages in Canada calls for a review of the drug supply system to identify underlying causes of supply problems and a monitoring unit to track drug production disruptions in Canada and abroad

2016

June 1, 2016

National Pharmacare in Canada: Getting There from Here

In a submission to the House of Commons Standing Committee on Health, the CMA calls for federal leadership and financial contribution to support a national pharmacare program on par with Canada’s Medicare program

May 20, 2016

Direct-to-consumer advertising

CMA publishes a policy on direct-to-consumer advertising related to prescription drugs and other therapeutic interventions opposing the practice and calling for objective, evidence-based, plain-language information on prescription drugs for the public

2015

August 26, 2015

Resolution Supporting Development of a National Pharmacare Program

CMA General Council adopts resolution supporting development of an equitable and comprehensive national pharmacare program.
2010

July 13, 2010

Health Care Transformation in Canada: Change that Works, Care that Lasts

(Reviewed March 3, 2018) The CMA publishes Health Care Transformation in Canada, declaring its readiness to take a leadership position in making health care work better for Canadians and setting out a framework for transformation.

2009

December 4, 2009

Funding the continuum of care

(Reviewed March 3, 2018) In this policy, the CMA puts forward principles for nationally funding the continuum of care, with specific recommendations for pharmaceuticals and other areas.

Tools & Resources


Resource

Implementing pharmacare

Canada’s physicians are very concerned about their patients’ access to prescription medicines. This submission to the Federal Advisory Council on the Implementation of National Pharmacare explores how national pharmacare could be delivered and which drugs should be covered.

Tool

Medication use and seniors

Older Canadians are the largest users of prescription drugs. They’re also at greater risk of adverse drug interactions. This two-page policy summary defines the basic steps physicians should follow to ensure appropriate prescribing for seniors.

Get Involved

Join the conversation

Have your say on pharmacare issues by joining the CMA’s Member Voice e-Panel. You can review the results of our most recent prescription drugs member survey here.

Submit a policy proposal

CMA members can bring forward their ideas about health issues that should be included in our current and future advocacy work.

Related Resources


National Pharmacare in Canada: Getting There from Here

Our 2016 submission to the House of Commons Standing Committee on Health outlines why a national pharmacare program is needed and our recommendations for making it happen.

Pharmacare Now: Prescription Medicine Coverage for all Canadians

Read the findings of the 2018 House of Commons study on pharmacare and its recommendations for moving toward universal, single-payer, prescription drug coverage.